Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abeona Therapeutics (NQ: ABEO )

1.990 USD -0.150 (-7.01%)
Official Closing Price Updated: 5:35 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abeona Therapeutics

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Abeona Therapeutics to Present at UBS 2016 Global Healthcare Conference
Company CEO to Present on Wednesday, May 25th at 11:30 am ET 
From Marketwired News Releases
Abeona Therapeutics to Present at UBS 2016 Global Healthcare Conference
From Marketwired
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Violations of Delaware Law by Certain Officers and Directors of Abeona Therapeutics Inc.
Levi & Korsinsky announces it has commenced an investigation of Abeona Therapeutics Inc. 
From Business Wire News Releases
Abeona Therapeutics Doses First Patient in Phase 1/2 Trial in Patients with Sanfilippo Syndrome Type A (MPS IIIA)
From SBWire - Latest Press Releases
Abeona Therapeutics Doses First Patient in Phase 1/2 Trial With ABO-102 Gene Therapy for Patients With Sanfilippo Syndrome Type A (MPS IIIA)
From Marketwired
Abeona Therapeutics Doses First Patient in Phase 1/2 Trial With ABO-102 Gene Therapy for Patients With Sanfilippo Syndrome Type A (MPS IIIA)
First-In-Man Gene Therapy Delivering AAV by Single Intravenous Injection to Treat Central Nervous System and Peripheral Manifestations of Disease 
From Marketwired News Releases
Abeona Therapeutics Announces First Quarter 2016 Summary Financial Results and Recent Operational Highlights
Investor Conference Call to Be Held on Tuesday, May 17th at 10 am ET 
From Marketwired News Releases
Abeona Therapeutics Announces First Quarter 2016 Summary Financial Results and Recent Operational Highlights
From Marketwired
Abeona Therapeutics Appoints Christine Silverstein as Vice President of Investor Relations
Silverstein Brings Wall Street, Investor Relations and Public Relations Expertise 
From Marketwired News Releases
Abeona Therapeutics Appoints Christine Silverstein as Vice President of Investor Relations
From Marketwired
Abeona Therapeutics to Present at Gene, Cell and Molecular Therapies for Inherited Metabolic Diseases Meeting
From Marketwired News Releases
Abeona Therapeutics to Present at Gene, Cell and Molecular Therapies for Inherited Metabolic Diseases Meeting
From Marketwired
Abeona Therapeutics to Present at Alliance of Regenerative Medicine's (ARM) 4th Annual Cell & Gene Therapy Investor Day
From Marketwired News Releases
Abeona Therapeutics to Present at the 28th Annual ROTH Conference
From Marketwired News Releases
Abeona Therapeutics Announces Fourth Quarter and Full Year 2015 Summary Financial Results and Recent Operational Highlights
From Marketwired News Releases
Abeona Therapeutics Highlights New Preclinical Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) Data at WORLDSymposium(TM) 2016
From Marketwired News Releases
Abeona Therapeutics Announces FDA Allowance of Investigational New Drug (IND) for Systemic AAV Phase 1/2 Clinical Study With ABO-102 Gene Therapy for Patients With Sanfilippo Syndrome Type A (MPS IIIA
From Marketwired News Releases
Abeona Therapeutics, Inc. to Present on CRISPR/CAS9 Technology Platform Progress at CRISPR Precision Gene Editing Congress
From Marketwired News Releases
Abeona Therapeutics to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
From Marketwired News Releases
Abeona Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference
From Marketwired News Releases
Abeona Therapeutics Announces Initial European Regulatory Approvals for Phase 1/2 Gene Therapy Clinical Studies for Patients with Sanfilippo Syndrome
From SBWire - Latest Press Releases
Abeona Therapeutics Announces Initial European Regulatory Approvals for Phase 1/2 Gene Therapy Clinical Studies for Patients With Sanfilippo Syndromes Type A (MPS IIIA) and Type B (MPS IIIB)
From Marketwired News Releases
Abeona Therapeutics to Present at Piper Jaffray 27th Annual Healthcare Conference
From Marketwired News Releases
Direction of Market Influences - Research on EVINE Live, hhgregg, Abeona Therapeutics and Edap Tms
Tags Business & Professional Services
From ACCESSWIRE
Abeona Therapeutics to Present at Jefferies 2015 Global Healthcare Conference
From Marketwired News Releases
Abeona Therapeutics Reports Financial Results and Highlights for Third Quarter 2015
From Marketwired News Releases
Abeona Therapeutics Announces License for Next Generation AAV Delivery Vector for Fanconi Anemia and Rare Blood Disease Platform
From SBWire - Latest Press Releases
Abeona Therapeutics Announces License for Next Generation AAV Delivery Vector for Fanconi Anemia and Rare Blood Disease Platform
From Marketwired News Releases
Abeona Therapeutics to Present at 2015 Stem Cell Meeting on the Mesa
From Marketwired News Releases
Abeona Therapeutics to Present at 2015 Rodman & Renshaw Annual Global Investment Conference
From Marketwired News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.